Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 609
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03337451 | Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome | ||
| NCT00831766 | Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | ||
| NCT06909357 | Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients | ||
| NCT00358319 | Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma | ||
| NCT02779855 | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer | ||
| NCT00006033 | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer | ||
| NCT02901548 | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | ||
| NCT01489527 | Preparedness Study - HPV Vaccine | ||
| NCT06193486 | Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC | ||
| NCT02313272 | Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas | ||
| NCT00215956 | A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma | ||
| NCT04101422 | Utilizing Augmented Reality as an Adjunct for Smoking Cessation | ||
| NCT01324180 | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | ||
| NCT02403310 | A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML | ||
| NCT00006088 | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors | ||
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | ||
| NCT05798780 | The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | ||
| NCT06519097 | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) | ||
| NCT04745559 | Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy | ||
| NCT00606008 | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | ||
| NCT03628209 | Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma | ||
| NCT06238921 | Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases | ||
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) | ||
| NCT04151667 | Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma | ||
| NCT00215930 | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer | ||
| NCT03043599 | Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer | ||
| NCT05757219 | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy | ||
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | ||
| NCT05873439 | Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC | ||
| NCT05763563 | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy | ||
| NCT00673738 | Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) | ||
| NCT06560398 | Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S) | ||
| NCT02186834 | Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma | ||
| NCT06497569 | Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer | ||
| NCT05070403 | Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma | ||
| NCT06835387 | Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors | ||
| NCT01531205 | Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL | ||
| NCT06253845 | Study of CG0070 After Transurethral Resection in Patients With IR NMIBC | ||
| NCT02063724 | HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer | ||
| NCT04996823 | Axitinib + Ipilimumab in Advanced Melanoma | ||
| NCT00153933 | Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT04741997 | Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma | ||
| NCT01111526 | Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) | ||
| NCT06844097 | Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals | ||
| NCT00231465 | Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer | ||
| NCT01010854 | Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer | ||
| NCT07249775 | A First-in-Human Study of FID-022 in Solid Tumor Patients | ||
| NCT06855212 | Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC |
